Chiltern International Ltd is a leading global Contract Research Organization with extensive experience in conducting and staffing global Phase I to Phase IV clinical trials across a broad therapeutic range. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services.